BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27321310)

  • 1. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
    Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
    Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes.
    Buraczynska M; Wacinski P; Zukowski P; Dragan M; Ksiazek A
    J Diabetes Complications; 2014; 28(1):35-9. PubMed ID: 24075694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.
    Buraczynska M; Baranowicz-Gaszczyk I; Tarach J; Ksiazek A
    Hum Immunol; 2009 Feb; 70(2):121-4. PubMed ID: 19135114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 polymorphisms seem not to be associated with prediabetes and type 2 diabetes but predispose to diabetic retinopathy; TLR4 polymorphisms in glucose continuum.
    Zaharieva ET; Kamenov ZA; Savov AS
    Endocr Regul; 2017 Jul; 51(3):137-144. PubMed ID: 28858846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes.
    Xu Y; Jiang Z; Huang J; Meng Q; Coh P; Tao L
    Br J Ophthalmol; 2015 Sep; 99(9):1301-5. PubMed ID: 25947554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy.
    Ciccacci C; Di Fusco D; Cacciotti L; Morganti R; D'Amato C; Novelli G; Sangiuolo F; Spallone V; Borgiani P
    Acta Diabetol; 2013 Oct; 50(5):789-99. PubMed ID: 22843023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease.
    Manolakis AC; Kapsoritakis AN; Tiaka EK; Sidiropoulos A; Gerovassili A; Satra M; Vamvakopoulou D; Tsiopoulos F; Papanas N; Skoularigis I; Potamianos SP; Vamvakopoulos N
    Eur J Endocrinol; 2011 Aug; 165(2):261-7. PubMed ID: 21628510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
    Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
    Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications.
    Rudofsky G; Schlimme M; Schlotterer A; von Eynatten M; Reismann P; Tafel J; Grafe I; Morcos M; Nawroth P; Bierhaus A; Hamann A
    Diabetes Obes Metab; 2005 Jul; 7(4):455-9. PubMed ID: 15955133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions.
    Demirci H; Yurtcu E; Ergun MA; Yazici AC; Karasu C; Yetkin I
    Genet Test; 2008 Jun; 12(2):305-9. PubMed ID: 18554168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-10 gene polymorphisms in type 2 diabetes and its micro- and macrovascular complications.
    Buraczynska M; Wacinski P; Stec A; Kuczmaszewska A
    J Diabetes Complications; 2013; 27(1):54-8. PubMed ID: 23021796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
    El-Lebedy D; Raslan HM; Mohammed AM
    Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
    Buraczynska M; Baranowicz-Gaszczyk I; Borowicz E; Ksiazek A
    Nephron Physiol; 2007; 106(4):p69-75. PubMed ID: 17622752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FTO variant is associated with chronic complications of diabetes mellitus in Czech population.
    Hubacek JA; Dlouha D; Klementova M; Lanska V; Neskudla T; Pelikanova T
    Gene; 2018 Feb; 642():220-224. PubMed ID: 29154870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic associated complications of type 2 diabetes mellitus.
    Wong YH; Wong SH; Wong XT; Yap QY; Yip KY; Wong LZ; Chellappan DK; Bhattamisra SK; Candasamy M
    Panminerva Med; 2022 Jun; 64(2):274-288. PubMed ID: 34609116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.
    Park HK; Ahn CW; Lee GT; Kim SJ; Song YD; Lim SK; Kim KR; Huh KB; Lee HC
    Diabetes Res Clin Pract; 2002 Feb; 55(2):151-7. PubMed ID: 11796181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of variants rs5030717 and rs5030718 of TLR4 in the risk prediction of nephropathy, hypertension and dyslipidaemia in type 2 diabetes mellitus.
    Abbas SA; Raza ST; Mir SS; Siddiqi Z; Zaidi A; Zaidi ZH; Mahdi F
    Br J Biomed Sci; 2018 Oct; 75(4):163-168. PubMed ID: 30211669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates.
    ElHajj Chehadeh S; Sayed NS; Abdelsamad HS; Almahmeed W; Khandoker AH; Jelinek HF; Alsafar HS
    Front Endocrinol (Lausanne); 2021; 12():751885. PubMed ID: 35069435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.